Skip to main content

Table 1 Patient demographic characteristics

From: Effect of low-dose atrial natriuretic peptide in critically ill patients with acute kidney injury: a retrospective, single-center study with propensity-score matching

Characteristic

Overall

Control group

Treatment group

p value

Number of patients

1374

1047

327

 

Age (years)

68 (57–76)

67 (55–76)

71 (61–78)

< 0.001

Male sex

919 (66.9)

702 (67.0)

217 (66.4)

0.818

Height (cm)

164 (156–169)

164 (156–169)

164 (156–169)

0.59

Body weight (kg)

59 (50–68)

59 (50–68)

58 (50–68)

0.762

ICU admission route

   

0.055

 OR (elective)

404 (29.4)

291 (27.8)

113 (34.6)

 

 OR (emergency)

223 (16.2)

177 (16.9)

46 (14.1)

 

 Emergency department

336 (24.5)

270 (25.8)

66 (20.2)

 

 Ward

375 (27.3)

284 (27.1)

91 (27.8)

 

 Other hospital

36 (2.6)

25 (2.4)

11 (3.4)

 

Comorbidity

 Hematologic disease

51 (3.7)

27 (2.6)

24 (7.3)

< 0.001

 Metastatic cancer

49 (3.6)

39 (3.7)

10 (3.1)

0.57

 Immunosuppression

123 (9.0)

86 (8.2)

37 (11.3)

0.086

 Liver failure

39 (2.8)

26 (2.5)

13 (4.0)

0.156

Primary damaged organ

   

0.117

 Cardiovascular

550 (40.0)

423 (40.4)

127 (38.8)

 

 Respiratory

237 (17.2)

181 (17.3)

56 (17.1)

 

 Digestive

239 (17.4)

187 (17.9)

52 (15.9)

 

 Neurologic

212 (15.4)

147 (14.0)

65 (19.9)

 

 Other

136 (9.9)

109 (10.4)

27 (8.3)

 

Infection at ICU admission

254 (18.5)

201 (19.2)

53 (16.2)

0.224

NPPV

147 (10.7)

108 (10.3)

39 (11.9)

0.411

MV duration (h) (n = 837)

17.5 (10.0–68.8)

17.5 (10.3–64.9)

16.6 (8.9–87.7)

0.821

APACHE II score

18 (14–22)

18 (14–22)

18 (14–23)

0.384

Serum creatinine (μmol/L)

 Baseline

73 (63–86)

73 (62–82)

76 (66–99)

< 0.001

 ICU admission

87 (65–134)

81 (61–122)

107 (81–152)

< 0.001

 AKI diagnosis

90 (65–141)

83 (60–126)

123 (88–171)

< 0.001

ICU-AKI (h)

12.7 (7.4–25.0)

13.9 (7.7–27.6)

10.1 (6.7–15.6)

< 0.001

  1. Data are presented as no. (%) or as median (interquartile range; 25th–75th percentile)
  2. AKI acute kidney injury, APACHE II Acute Physiology and Chronic Health Evaluation II, ICU intensive care unit, ICU-AKI h duration between ICU admission and AKI diagnosis, MV mechanical ventilation, NPPV noninvasive positive-pressure ventilation, OR operating room